Technical Analysis for ALC - Alcon Inc.

Grade Last Price % Change Price Change
grade C 58.31 0.71% 0.41
ALC closed up 0.71 percent on Monday, June 17, 2019, on 45 percent of normal volume.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical ALC trend table...

Date Alert Name Type % Chg
Bullish Engulfing Bullish 0.00%
Outside Day Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Gapped Down Weakness 0.71%
Fell Below 20 DMA Bearish -1.22%
20 DMA Support Bullish -1.72%
Up 3 Days in a Row Strength -1.72%
Up 4 Days in a Row Strength -1.72%
Up 5 Days in a Row Strength -1.72%
Crossed Above 20 DMA Bullish -1.55%

Older signals for ALC ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:
Profile
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care.
Glaucoma Ophthalmology Vision Blindness Cataract Perception Retinal Diseases Alcon Contact Lenses Senses Visual System
Is ALC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 0 bearish and 5 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 16 Alcon, Inc. (ALC) Q1 2019 Earnings Call Transcript
May 15 Alcon revenue in-line
May 15 Alcon Reports First Quarter 2019 Trading Update
May 10 The Daily Biotech Pulse: FibroGen Kidney Disease Trial Disappoints, Medtronic To Buy Titan Spine, Puma's Weak Breast Cancer Drug Sales
May 8 Alcon: A Secular Grower
May 3 The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen
May 2 The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data
May 1 Alcon to Showcase New Clinical Data, Innovative Technology at American Society of Cataract and Refractive Surgery 2019 Annual Meeting
Apr 25 Alcon to Participate in Bank of America Merrill Lynch and Jefferies Healthcare Conferences
Apr 23 Health-care earnings: ‘Medicare for all’ looms large
See more ALC news...
Indicators
Indicator Value
52 Week High 63.73
52 Week Low 53.78
Average Volume 1,828,118
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 58.791
10-Day Moving Average 58.803
Average True Range 0.9733
ADX 8.79
+DI 20.8671
-DI 26.6658
Chandelier Exit (Long, 3 ATRs ) 59.1701
Chandelier Exit (Short, 3 ATRs ) 60.5699
Upper Bollinger Band 59.6712
Lower Bollinger Band 57.9108
Percent B (%b) 0.23
BandWidth 2.994336
MACD Line 0.0458
MACD Signal Line 0.2102
MACD Histogram -0.1644
Fundamentals Value
Market Cap 1.35 Billion
Num Shares 23.2 Million
EPS -1.74
Price-to-Earnings (P/E) Ratio -33.45
Price-to-Sales 1.24
Price-to-Book 1.03
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 59.60
Resistance 3 (R3) 59.52 59.02 59.39
Resistance 2 (R2) 59.02 58.69 59.06 59.31
Resistance 1 (R1) 58.66 58.49 58.84 58.74 59.24
Pivot Point 58.16 58.16 58.25 58.20 58.16
Support 1 (S1) 57.80 57.83 57.98 57.88 57.38
Support 2 (S2) 57.30 57.63 57.34 57.31
Support 3 (S3) 56.94 57.30 57.24
Support 4 (S4) 57.02